All Regio Biosciences Enters into License Agreement with AstraZeneca for Phase 2a Asset in Peripheral Artery Disease (PAD) February 03, 2022 07:05 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Regio Biosciences (Regio),a Hibiscus BioVentures…levikinzerFebruary 4, 2022
All Hibiscus BioVentures Partners with the Barbara Ann Karmanos Cancer Institute to Advance Translational Cancer Research - Partnership aims to drive innovation and clinical development of novel therapeutics for cancer treatment…dantetzlJanuary 5, 2022
All connectRN raises $76M for healthcare worker staffing, networking The company said the latest round brings its total raise to more than $100 million.…dantetzlDecember 9, 2021
All Cellevolve Launches with Acclaimed Investors and Pivotal Manufacturing Partnership, Focused on Accelerating the Commercialization of Novel Cell Therapies Secured seed financing of $6M USD from investors including biopharmaceutical manufacturing company, National Resilience, Inc.…dantetzlNovember 18, 2021
AllAsclepix Therapeutics AsclepiX Therapeutics, Inc. Appoints Robert J. Dempsey as Chief Executive Officer and President Pharmaceutical Industry Veteran Further Strengthens the Executive Team BALTIMORE, MD, March 17, 2021 – AsclepiX…levikinzerMarch 17, 2021
AllAsclepix Therapeutics AsclepiX Therapeutics partners with Notal Vision on Home OCT remote monitoring in DME and AMD clinical trials The technology could set new standards for data enrichment and patient-centric conduct of clinical trials…levikinzerFebruary 24, 2021